Omalizumab Subcutaneous and Prohist LQ
Determining the interaction of Omalizumab Subcutaneous and Prohist LQ and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: phenylephrine / triprolidine
Brand name: Prohist LQ, Histex-PE, Histex PE
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Prolensa
- Omalizumab Subcutaneous-Prolensa ophthalmic
- Omalizumab Subcutaneous-Proleukin
- Omalizumab Subcutaneous-Prolex D
- Omalizumab Subcutaneous-Prolia
- Omalizumab Subcutaneous-Prolida Patch
- Prohist LQ-Ombitasvir, Paritaprevir, and Ritonavir
- Prohist LQ-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Prohist LQ-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Prohist LQ-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Prohist LQ-Omeclamox-Pak
- Prohist LQ-Omega-3 Fatty Acid Capsules